Company
Ouro Medicines
Ouro Medicines is a biotechnology company developing immune reset therapeutics for people living with chronic immune-mediated diseases.
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Ouro Medicines is a San Francisco-based biotechnology company developing immune reset therapeutics for people living with chronic autoimmune diseases. Founded by Monograph in partnership with GSK, the Series A was co-led by TPG Life Sciences Innovations, NEA, and Norwest Venture Partners in December 2024.
Loading relationship preview